Latest Hodgkin's lymphoma Stories
SEATTLE, April 28, 2015 /PRNewswire/ -- Adaptive Biotechnologies today announced the recent publication of a study conducted with researchers at The University of Texas MD Anderson Cancer Center
SEATTLE, April 22, 2015 /PRNewswire/ -- Adaptive Biotechnologies today announced the recent publication of a study demonstrating that analysis of circulating tumor DNA (ctDNA) using the company's
WHIPPANY, N.J., April 14, 2015 /PRNewswire/ -- Bayer HealthCare today announced the expansion of its global clinical development program for the investigational oncology compound copanlisib (BAY
Esten and leukemia survivor daughter Addie to join thousands across the country for Light The Night Walks to raise funds for cancer cures WHITE PLAINS, N.Y., April 13, 2015 /PRNewswire/
Influential Leaders Compete to Raise Funds in Honor of Local Blood Cancer Survivors SANTA ROSA, Calif., April 8, 2015 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's
Mesothelioma lawyers of The Law Office of Melinda J. Helbock A.P.C.
WHITE PLAINS, N.Y., March 30, 2015 /PRNewswire-USNewswire/ -- A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype
RnRMarketResearch.com adds "T-Cell Leukemia and Peripheral T-Cell Lymphomas - Pipeline Review, H1 2015" to its store.
BEVERLY HILLS, Calif., March 24, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc.
Second cohort underway in non-Hodgkin's lymphoma patients SAN DIEGO, March 19, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) has completed the first cohort in a Phase 1